Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Watts

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Neuro-Oncology Practice|August 7, 2019
Quality improvement of neuro-oncology services: integrating the routine collection of patient-reported, health-related quality-of-life measuresRocío Fernández-Méndez, Rebecca J Rastall, William A Sage, et al.
The Journal of Biological Chemistry|March 28, 2006
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornificationTsing Cheng, Kiyotaka Hitomi, Ivonne M J J van Vlijmen-Willems, et al.
Genes & Development|March 21, 2013
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent mannerStefan H Stricker, Andrew Feber, Pär G Engström, et al.
Insights Into Imaging|July 19, 2020
Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesionsVijay Sawlani, Markand Dipankumar Patel, Nigel Davies, et al.
Neuro-Oncology Advances|July 17, 2023
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategiesMegan Houweling, Anna Giczewska, Kulsoom Abdul, et al.
Nature Communications|October 29, 2014
Loss of beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotypeVicky Louise Morrison, Martyn John James, Katarzyna Grzes, et al.
NPJ Genomic Medicine|December 22, 2017
Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastomaEun-Ang Raiber, Dario Beraldi, Sergio Martínez Cuesta, et al.
European Radiology|March 20, 2019
Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histologyFulvio Zaccagna, Frank Riemer, Andrew N Priest, et al.
Science Translational Medicine|July 17, 2020
Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistanceLeila Akkari, Robert L Bowman, Jeremy Tessier, et al.
Brain : a Journal of Neurology|May 3, 2007
Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cellsAlexis J Joannides, Daniel J Webber, Olivier Raineteau, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Neuro-Oncology Practice|August 7, 2019
Quality improvement of neuro-oncology services: integrating the routine collection of patient-reported, health-related quality-of-life measuresRocío Fernández-Méndez, Rebecca J Rastall, William A Sage, et al.
The Journal of Biological Chemistry|March 28, 2006
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornificationTsing Cheng, Kiyotaka Hitomi, Ivonne M J J van Vlijmen-Willems, et al.
Genes & Development|March 21, 2013
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent mannerStefan H Stricker, Andrew Feber, Pär G Engström, et al.
Insights Into Imaging|July 19, 2020
Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesionsVijay Sawlani, Markand Dipankumar Patel, Nigel Davies, et al.
Neuro-Oncology Advances|July 17, 2023
Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategiesMegan Houweling, Anna Giczewska, Kulsoom Abdul, et al.
Nature Communications|October 29, 2014
Loss of beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotypeVicky Louise Morrison, Martyn John James, Katarzyna Grzes, et al.
NPJ Genomic Medicine|December 22, 2017
Base resolution maps reveal the importance of 5-hydroxymethylcytosine in a human glioblastomaEun-Ang Raiber, Dario Beraldi, Sergio Martínez Cuesta, et al.
European Radiology|March 20, 2019
Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histologyFulvio Zaccagna, Frank Riemer, Andrew N Priest, et al.
Science Translational Medicine|July 17, 2020
Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistanceLeila Akkari, Robert L Bowman, Jeremy Tessier, et al.
Brain : a Journal of Neurology|May 3, 2007
Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cellsAlexis J Joannides, Daniel J Webber, Olivier Raineteau, et al.
Pageof 19